Literature DB >> 27262480

Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece.

John N Yfantopoulos1, Athanasios E Chantzaras2.   

Abstract

PURPOSE: To validate and compare the psychometric properties of the EQ-5D-3L with the EQ-5D-5L classification systems in Greece.
METHODS: Participants (n = 2279) over 40 years old, sampled from the greater area of Athens using a multistage stratified quota sampling method, completed both EQ-5D versions, while information was also collected on socio-demographics and health-related characteristics. The EQ-5D-5L and EQ-5D-3L were evaluated in terms of agreement, ceiling effects, redistribution and inconsistency, informativity, and convergent and known-groups validity.
RESULTS: The agreement between the EQ-5D-3L and EQ-5D-5L was high (ICC = 0.85). Ceiling effects decreased significantly in the EQ-5D-5L in all domains (P < 0.001), with "usual activities" (-21.4 %) and "self-care" (-20.1 %) showing the highest absolute and "anxiety/depression" the highest relative reduction (-32.46 %). Inconsistency was low (5.7 %). The increase in prevalence of problems was larger than the decrease in their severity, resulting in a lower mean health utility for the EQ-5D-5L. Overall absolute and relative informativity improved by 70.5 % and 16.4 %, respectively, in the EQ-5D-5L. Both instruments exhibited good convergent and known-groups validity, with evidence of a considerably better convergent performance and discriminatory ability of the EQ-5D-5L.
CONCLUSIONS: Both EQ-5D versions demonstrated good construct validity and had consistent redistribution. The EQ-5D-5L system may be preferable to the EQ-5D-3L, as it exhibited superior performance in terms of lower ceiling effects, higher absolute and relative informativity, and improved convergent and known-groups validity efficiency.

Entities:  

Keywords:  EQ-5D; Greece; Health-related quality of life; Psychometrics; Validity

Mesh:

Year:  2016        PMID: 27262480     DOI: 10.1007/s10198-016-0807-0

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  43 in total

Review 1.  EQ-5D: a measure of health status from the EuroQol Group.

Authors:  R Rabin; F de Charro
Journal:  Ann Med       Date:  2001-07       Impact factor: 4.709

Review 2.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

3.  Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.

Authors:  A Simon Pickard; Maria C De Leon; Thomas Kohlmann; David Cella; Sarah Rosenbloom
Journal:  Med Care       Date:  2007-03       Impact factor: 2.983

Review 4.  Psychometric considerations in evaluating health-related quality of life measures.

Authors:  R D Hays; R Anderson; D Revicki
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

5.  The quality of eight health status measures were compared for chronic opioid dependence.

Authors:  Bohdan Nosyk; Huiyung Sun; Daphne P Guh; Eugenia Oviedo-Joekes; David C Marsh; Suzanne Brissette; Martin T Schechter; Aslam H Anis
Journal:  J Clin Epidemiol       Date:  2010-03-17       Impact factor: 6.437

Review 6.  The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus.

Authors:  M F Janssen; E I Lubetkin; J P Sekhobo; A S Pickard
Journal:  Diabet Med       Date:  2011-04       Impact factor: 4.359

7.  Psychometric properties of the EQ-5D-5L in the general population of South Korea.

Authors:  Tae Hyup Kim; Min-Woo Jo; Sang-il Lee; Seon Ha Kim; Son Mi Chung
Journal:  Qual Life Res       Date:  2012-12-06       Impact factor: 4.147

8.  A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 years.

Authors:  Garry R Barton; Tracey H Sach; Anthony J Avery; Claire Jenkinson; Michael Doherty; David K Whynes; Kenneth R Muir
Journal:  Health Econ       Date:  2008-07       Impact factor: 3.046

9.  Using the bootstrap to establish statistical significance for relative validity comparisons among patient-reported outcome measures.

Authors:  Nina Deng; Jeroan J Allison; Hua Julia Fang; Arlene S Ash; John E Ware
Journal:  Health Qual Life Outcomes       Date:  2013-05-31       Impact factor: 3.186

10.  Validity and reliability of the EQ-5D-3L™ among a paediatric injury population.

Authors:  Mariana Brussoni; Sami Kruse; Kerry Walker
Journal:  Health Qual Life Outcomes       Date:  2013-09-17       Impact factor: 3.186

View more
  21 in total

1.  Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population.

Authors:  Asrul Akmal Shafie; Annushiah Vasan Thakumar; Ching Jou Lim; Nan Luo
Journal:  Qual Life Res       Date:  2018-10-13       Impact factor: 4.147

2.  Health-related quality of life and health utilities in insulin-treated type 2 diabetes: the impact of related comorbidities/complications.

Authors:  John Yfantopoulos; Athanasios Chantzaras
Journal:  Eur J Health Econ       Date:  2020-03-03

3.  Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.

Authors:  Adrienn Katalin Poór; Fanni Rencz; Valentin Brodszky; László Gulácsi; Zsuzsanna Beretzky; Bernadett Hidvégi; Péter Holló; Sarolta Kárpáti; Márta Péntek
Journal:  Qual Life Res       Date:  2017-09-05       Impact factor: 4.147

4.  Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness.

Authors:  Amaia Bilbao; Lidia García-Pérez; Juan Carlos Arenaza; Isidoro García; Gloria Ariza-Cardiel; Elisa Trujillo-Martín; Maria João Forjaz; Jesús Martín-Fernández
Journal:  Qual Life Res       Date:  2018-07-05       Impact factor: 4.147

5.  The effects of golimumab on work productivity and quality of life among work-active axial spondyloarthritis and psoriatic arthritis patients treated in the routine care in Greece: the 'GO-UP' study.

Authors:  Panagiotis Athanassiou; Anastasios Kotrotsios; Ioannis Kallitsakis; Andreas Bounas; Theodoros Dimitroulas; Alexandros Garyfallos; Maria G Tektonidou; Giorgos Vosvotekas; Achilleas Livieratos; Evangelia Petrikkou; Gkikas Katsifis
Journal:  Qual Life Res       Date:  2021-11-28       Impact factor: 4.147

6.  Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.

Authors:  Juan Zhu; Xin-Xin Yan; Cheng-Cheng Liu; Hong Wang; Le Wang; Su-Mei Cao; Xian-Zhen Liao; Yun-Feng Xi; Yong Ji; Lin Lei; Hai-Fan Xiao; Hai-Jing Guan; Wen-Qiang Wei; Min Dai; Wanqing Chen; Ju-Fang Shi
Journal:  Qual Life Res       Date:  2020-09-15       Impact factor: 4.147

7.  The impact of common chronic conditions on health-related quality of life: a general population survey in Iran using EQ-5D-5L.

Authors:  Ali Akbari Sari; Fereshteh Karimi; Zahra Emrani; Hojjat Zeraati; Alireza Olyaeemanesh; Rajabali Daroudi
Journal:  Cost Eff Resour Alloc       Date:  2021-05-13

8.  Health-related quality of life in the Brazilian Amazon: a population-based cross-sectional study.

Authors:  Marcus Tolentino Silva; Monica Caicedo Roa; Tais Freire Galvao
Journal:  Health Qual Life Outcomes       Date:  2017-08-14       Impact factor: 3.186

9.  Health-Related Quality of Life of the General German Population in 2015: Results from the EQ-5D-5L.

Authors:  Manuel B Huber; Julia Felix; Martin Vogelmann; Reiner Leidl
Journal:  Int J Environ Res Public Health       Date:  2017-04-16       Impact factor: 3.390

10.  A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D.

Authors:  Ines Buchholz; Mathieu F Janssen; Thomas Kohlmann; You-Shan Feng
Journal:  Pharmacoeconomics       Date:  2018-06       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.